Amwell (AMWL) Tops Q3 EPS by 4c

Amwell (NYSE: AMWL) reported Q3 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $62.2 million versus the consensus estimate of $65.35 million.

GUIDANCE:

Amwell sees FY2021 revenue of $246-253 million, versus the consensus of $255 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Barclays Downgrades Community Health (CYH) to Underweight
• Barclays Downgrades Universal Health Services (UHS) to Equalweight